KOMO Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 1st St Ste 18, Cambridge, Massachuse...Website
www.komobiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About KOMO Biosciences
KOMO Biosciences is a next-generation precision genome engineering technology company specializing in high-efficiency integrases that provide significant advancements in life sciences. The company focuses on enhancing therapeutic development and manufacturing processes with its innovative, non-viral precision genome editing tools. Their advanced cell line platform offers the capability to insert large genes into the human genome at unprecedented efficiencies, targeting applications in cell line development and biologics. KOMO Biosciences aims to address the limitations of traditional genome engineering methods while contributing to pandemic preparedness.Explore more
KOMO Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KOMO Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when KOMO Biosciences launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once KOMO Biosciences has new funding data
Click to see if KOMO Biosciences had a recent Job posting/layoffs
KOMO Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if KOMO Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at KOMO Biosciences
Check if KOMO Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on KOMO Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined KOMO Biosciences as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
KOMO Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KOMO Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KOMO Biosciences.
KOMO Biosciences News & Media
KOMO Biosciences Grants Research Evaluation License to Syngenta to Explore Precision Genome Modification in Maize
KOMO Biosciences announced that it has granted Syngenta , a Research Evaluation License to assess aspects of KOMO’s proprietary KOMbine™ platform.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding KOMO Biosciences
Sign Up For FreeTo access detailed company insights
KOMO Biosciences is a next-generation precision genome engineering technology company specializing in high-efficiency integrases that provide significant advancements in life sciences. The company focuses on enhancing therapeutic development and manufacturing processes with its innovative, non-viral precision genome editing tools. Their advanced ce... Read More
